NATIONAL CANCER CENTER, NATIONAL RESEARCH AND DEVELOPMENT AGENCY

NATIONAL CANCER CENTER, NATIONAL RESEARCH AND DEVELOPMENT AGENCY specializes in advanced genomic and phenotypic laboratory testing services, with a focused expertise in whole-genome sequencing and high-throughput data preparation for cancer research. The contractor delivers precision oncology support through sophisticated molecular diagnostics, particularly in the analysis of lung adenocarcinoma cohorts, including the isolation and characterization of genetic variants in never-smoking female populations. Their technical capabilities encompass next-generation sequencing workflows, bioinformatics data curation, and clinical-grade sample processing aligned with international research standards. The organization’s differentiation lies in its capacity to execute complex, population-specific genomic studies requiring stringent quality control and ethical data handling protocols. The contractor maintains a consistent relationship with the Department of Health and Human Services, providing specialized laboratory services that support national cancer research initiatives. Their work for HHS centers on large-scale genomic data generation for epidemiological and translational studies, reinforcing a pattern of collaboration focused on precision medicine and cancer etiology. The primary industry focus is in Testing Laboratories and Services (NAICS 541380), where the contractor operates at the intersection of clinical diagnostics and biomedical research. They serve the oncology research vertical with specialized competence in cancer genomics, phenotypic profiling, and biomarker discovery, positioning them as a niche provider for federally funded cancer surveillance and molecular epidemiology programs. As a research and development agency based in Chuo-ku, the entity operates under a public institutional structure with no commercial certifications on record. Its government market presence is defined by its role as a national research institution conducting mission-critical scientific services for U.S. health agencies, with no indication of commercial or small business status.